Logo image of 33L.DE

LULULEMON ATHLETICA INC (33L.DE) Stock Fundamental Analysis

FRA:33L - Deutsche Boerse Ag - US5500211090 - Common Stock - Currency: EUR

198.14  -0.84 (-0.42%)

Fundamental Rating

7

Overall 33L gets a fundamental rating of 7 out of 10. We evaluated 33L against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the health and profitability get an excellent rating, making 33L a very profitable company, without any liquidiy or solvency issues. 33L has a decent growth rate and is not valued too expensively. This makes 33L very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

33L had positive earnings in the past year.
33L had a positive operating cash flow in the past year.
Each year in the past 5 years 33L has been profitable.
In the past 5 years 33L always reported a positive cash flow from operatings.
33L.DE Yearly Net Income VS EBIT VS OCF VS FCF33L.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

Looking at the Return On Assets, with a value of 24.33%, 33L belongs to the top of the industry, outperforming 97.78% of the companies in the same industry.
Looking at the Return On Equity, with a value of 42.14%, 33L belongs to the top of the industry, outperforming 95.56% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 30.39%, 33L belongs to the top of the industry, outperforming 97.78% of the companies in the same industry.
33L had an Average Return On Invested Capital over the past 3 years of 29.73%. This is significantly above the industry average of 10.62%.
The 3 year average ROIC (29.73%) for 33L is below the current ROIC(30.39%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROIC 30.39%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
33L.DE Yearly ROA, ROE, ROIC33L.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

The Profit Margin of 33L (16.82%) is better than 88.89% of its industry peers.
In the last couple of years the Profit Margin of 33L has remained more or less at the same level.
33L has a Operating Margin of 23.37%. This is amongst the best in the industry. 33L outperforms 88.89% of its industry peers.
In the last couple of years the Operating Margin of 33L has remained more or less at the same level.
33L's Gross Margin of 59.34% is in line compared to the rest of the industry. 33L outperforms 46.67% of its industry peers.
In the last couple of years the Gross Margin of 33L has remained more or less at the same level.
Industry RankSector Rank
OM 23.37%
PM (TTM) 16.82%
GM 59.34%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
33L.DE Yearly Profit, Operating, Gross Margins33L.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 33L is creating value.
The number of shares outstanding for 33L remains at a similar level compared to 1 year ago.
33L has less shares outstanding than it did 5 years ago.
There is no outstanding debt for 33L. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
33L.DE Yearly Shares Outstanding33L.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
33L.DE Yearly Total Debt VS Total Assets33L.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

33L has an Altman-Z score of 8.91. This indicates that 33L is financially healthy and has little risk of bankruptcy at the moment.
33L has a better Altman-Z score (8.91) than 93.33% of its industry peers.
33L has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.91
ROIC/WACC3.87
WACC7.86%
33L.DE Yearly LT Debt VS Equity VS FCF33L.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.28 indicates that 33L has no problem at all paying its short term obligations.
33L has a Current ratio of 2.28. This is in the better half of the industry: 33L outperforms 80.00% of its industry peers.
33L has a Quick Ratio of 1.23. This is a normal value and indicates that 33L is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.23, 33L is in the better half of the industry, outperforming 71.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 1.23
33L.DE Yearly Current Assets VS Current Liabilites33L.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.19% over the past year.
The Earnings Per Share has been growing by 24.37% on average over the past years. This is a very strong growth
Looking at the last year, 33L shows a quite strong growth in Revenue. The Revenue has grown by 9.39% in the last year.
33L shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.62% yearly.
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%

3.2 Future

Based on estimates for the next years, 33L will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.19% on average per year.
The Revenue is expected to grow by 7.99% on average over the next years.
EPS Next Y1.72%
EPS Next 2Y4.82%
EPS Next 3Y6.29%
EPS Next 5Y11.19%
Revenue Next Year6.48%
Revenue Next 2Y6.82%
Revenue Next 3Y7.01%
Revenue Next 5Y7.99%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
33L.DE Yearly Revenue VS Estimates33L.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
33L.DE Yearly EPS VS Estimates33L.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

33L is valuated correctly with a Price/Earnings ratio of 15.56.
Based on the Price/Earnings ratio, 33L is valued a bit cheaper than 71.11% of the companies in the same industry.
33L's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.69.
Based on the Price/Forward Earnings ratio of 14.23, the valuation of 33L can be described as correct.
33L's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 33L is cheaper than 75.56% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.29, 33L is valued a bit cheaper.
Industry RankSector Rank
PE 15.56
Fwd PE 14.23
33L.DE Price Earnings VS Forward Price Earnings33L.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

33L's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, 33L is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.99
EV/EBITDA 8.83
33L.DE Per share data33L.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 33L does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 33L may justify a higher PE ratio.
PEG (NY)9.03
PEG (5Y)0.64
EPS Next 2Y4.82%
EPS Next 3Y6.29%

0

5. Dividend

5.1 Amount

No dividends for 33L!.
Industry RankSector Rank
Dividend Yield N/A

LULULEMON ATHLETICA INC

FRA:33L (6/25/2025, 7:00:00 PM)

198.14

-0.84 (-0.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)06-05 2025-06-05/amc
Earnings (Next)08-27 2025-08-27/amc
Inst Owners96.5%
Inst Owner ChangeN/A
Ins Owners0.3%
Ins Owner ChangeN/A
Market Cap23.81B
Analysts74.63
Price Target278.14 (40.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-1.37%
Max EPS beat(2)2.91%
EPS beat(4)3
Avg EPS beat(4)2.92%
Min EPS beat(4)-1.37%
Max EPS beat(4)5.41%
EPS beat(8)7
Avg EPS beat(8)3.97%
EPS beat(12)10
Avg EPS beat(12)5.1%
EPS beat(16)14
Avg EPS beat(16)6.97%
Revenue beat(2)0
Avg Revenue beat(2)-1.17%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.92%
Revenue beat(4)0
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-3.46%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)4
Avg Revenue beat(12)-0.36%
Revenue beat(16)6
Avg Revenue beat(16)0.12%
PT rev (1m)-7.61%
PT rev (3m)-29.15%
EPS NQ rev (1m)-12.17%
EPS NQ rev (3m)-14.26%
EPS NY rev (1m)-0.86%
EPS NY rev (3m)-4.2%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 14.23
P/S 2.57
P/FCF 20.99
P/OCF 13.63
P/B 6.44
P/tB 6.72
EV/EBITDA 8.83
EPS(TTM)12.73
EY6.42%
EPS(NY)13.93
Fwd EY7.03%
FCF(TTM)9.44
FCFY4.76%
OCF(TTM)14.54
OCFY7.34%
SpS77.14
BVpS30.78
TBVpS29.51
PEG (NY)9.03
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 24.33%
ROE 42.14%
ROCE 42.89%
ROIC 30.39%
ROICexc 39.27%
ROICexgc 40.88%
OM 23.37%
PM (TTM) 16.82%
GM 59.34%
FCFM 12.24%
ROA(3y)20.32%
ROA(5y)18.95%
ROE(3y)35.25%
ROE(5y)32.87%
ROIC(3y)29.73%
ROIC(5y)26.99%
ROICexc(3y)45.65%
ROICexc(5y)41.54%
ROICexgc(3y)46.74%
ROICexgc(5y)45.9%
ROCE(3y)41.97%
ROCE(5y)38.1%
ROICexcg growth 3Y-2.73%
ROICexcg growth 5Y3.8%
ROICexc growth 3Y3.22%
ROICexc growth 5Y3.16%
OM growth 3Y2.55%
OM growth 5Y1.15%
PM growth 3Y3.21%
PM growth 5Y1.1%
GM growth 3Y0.89%
GM growth 5Y1.17%
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 152.77%
Cap/Sales 6.61%
Interest Coverage 250
Cash Conversion 68.04%
Profit Quality 72.77%
Current Ratio 2.28
Quick Ratio 1.23
Altman-Z 8.91
F-Score8
WACC7.86%
ROIC/WACC3.87
Cap/Depr(3y)181.68%
Cap/Depr(5y)168.92%
Cap/Sales(3y)7.05%
Cap/Sales(5y)6.53%
Profit Quality(3y)77.23%
Profit Quality(5y)86.23%
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y23.52%
EPS 5Y24.37%
EPS Q2Q%2.36%
EPS Next Y1.72%
EPS Next 2Y4.82%
EPS Next 3Y6.29%
EPS Next 5Y11.19%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y19.17%
Revenue growth 5Y21.62%
Sales Q2Q%7.32%
Revenue Next Year6.48%
Revenue Next 2Y6.82%
Revenue Next 3Y7.01%
Revenue Next 5Y7.99%
EBIT growth 1Y12.25%
EBIT growth 3Y22.21%
EBIT growth 5Y23.02%
EBIT Next Year21.76%
EBIT Next 3Y12.04%
EBIT Next 5Y10.61%
FCF growth 1Y122.59%
FCF growth 3Y16.77%
FCF growth 5Y32.6%
OCF growth 1Y61.42%
OCF growth 3Y17.83%
OCF growth 5Y27.7%